Understanding how the body's internal clock affects insulin-producing cells in the pancreas
Circadian Control of Pancreatic Beta-cell Maturation
This study is looking at how a special protein called Dec1 helps insulin-producing cells in the pancreas grow and adapt after birth, with the goal of finding new ways to improve insulin production and diabetes treatments, which could also help in creating better beta cells for transplants.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10615231 on NIH RePORTER |
What this research studies
This research investigates how pancreatic beta cells, which produce insulin, mature and adapt to changes after birth. It focuses on the role of a specific protein called Dec1, which is linked to the body's circadian rhythms, in regulating the development and function of these cells. By studying the effects of Dec1 on the genetic and molecular changes in beta cells, the research aims to uncover new ways to enhance insulin secretion and potentially improve treatments for diabetes. The findings could lead to better strategies for generating mature beta cells from stem cells for transplantation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for type 1 or type 2 diabetes, particularly those with early signs of beta cell dysfunction.
Not a fit: Patients who do not have any risk factors for diabetes or those with advanced diabetes complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for diabetes by enhancing the function of insulin-producing cells.
How similar studies have performed: Previous research has shown promising results in understanding the role of circadian rhythms in various cellular functions, suggesting potential success for this approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Alvarez, Juan R — University of Pennsylvania
- Study coordinator: Alvarez, Juan R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.